Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, April 04, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the.
Basilea Pharmaceutica AG: Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Basilea Pharmaceutica announced the FDA approved ZEVTERA for the treatment of adult patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis, and adult patients with acute bacterial skin and skin structure infections and for adult and pediatric patients with community-acquired bacterial pneumonia.
FDA approves Basilea s intravenous antibiotic Zevtera for three indications pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.